TNDM
Tandem Diabetes Care, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$19.90
−2.59%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0B | 1.0B | 940.2M | 747.7M | 801.2M |
| Cost of Revenue | 458.1M | 483.9M | 450.6M | 380.0M | 388.2M |
| Gross Profit | 583.3M | 530.8M | 489.6M | 367.7M | 413.0M |
| Operating Expenses | |||||
| R&D Expense | 186.9M | 174.8M | 198.9M | 248.4M | 170.2M |
| SG&A Expense | 439.4M | 434.1M | 389.8M | 352.5M | 335.7M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 626.3M | 609.0M | 588.7M | 600.9M | 505.8M |
| Cost and Expenses | 1.1B | 1.1B | 1.0B | 980.9M | 894.1M |
| Operating Income (EBIT) | (43.0M) | (78.1M) | (99.1M) | (233.2M) | (92.8M) |
| Non-Operating | |||||
| Interest Income | 10.4M | 9.1M | 18.0M | 22.9M | 6.1M |
| Interest Expense | 8.2M | 7.9M | 7.4M | 9.9M | 6.2M |
| Net Interest Income | 2.2M | 1.2M | 10.6M | 13.0M | (151.0K) |
| Other Non-Op Income/Expense | (18.0M) | (122.2M) | 7.3M | 13.0M | (4.0K) |
| Non-Operating Income (excl Interest) | 9.8M | 114.2M | 158.0K | (21.1M) | (4.3M) |
| EBT (Pre-Tax Income) | (61.0M) | (200.3M) | (91.9M) | (220.3M) | (92.9M) |
| Income Tax Expense | 2.3M | 4.4M | 4.2M | 2.4M | 1.7M |
| Bottom Line | |||||
| Net Income | (63.3M) | (204.7M) | (96.0M) | (222.6M) | (94.6M) |
| Earnings from Cont. Ops | (63.3M) | (204.7M) | (96.0M) | (222.6M) | (94.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (63.3M) | (204.7M) | (96.0M) | (222.6M) | (94.6M) |
| Per Share | |||||
| Basic EPS | ($0.93) | ($3.04) | ($1.47) | ($3.43) | ($1.47) |
| Diluted EPS | ($0.93) | ($3.04) | ($1.47) | ($3.43) | ($1.47) |
| Revenue Per Share | $15.23 | $15.08 | $14.36 | $11.52 | $12.49 |
| Shares | |||||
| Basic Shares Outstanding | 68.4M | 67.3M | 65.5M | 64.9M | 64.1M |
| Diluted Shares Outstanding | 68.4M | 67.3M | 65.5M | 65.0M | 64.1M |
| Profitability Metrics | |||||
| EBITDA | (30.3M) | (174.7M) | (99.1M) | (196.5M) | (74.2M) |
| D&A | 22.5M | 17.7M | 158.0K | 15.7M | 14.3M |
| EBIT | (52.8M) | (192.4M) | (99.3M) | (212.2M) | (88.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026